BR0014146A - Aparelho e método para anestesiar a região cervical de uma fêmea - Google Patents

Aparelho e método para anestesiar a região cervical de uma fêmea

Info

Publication number
BR0014146A
BR0014146A BR0014146-1A BR0014146A BR0014146A BR 0014146 A BR0014146 A BR 0014146A BR 0014146 A BR0014146 A BR 0014146A BR 0014146 A BR0014146 A BR 0014146A
Authority
BR
Brazil
Prior art keywords
female
cervical region
anesthetic
ring
anesthetizing
Prior art date
Application number
BR0014146-1A
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Francine Kay
Louis J Mestichelli
Ann Elizabeth Gooding
Suzanne Wilford Ruth
Original Assignee
Fei Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fei Technologies Inc filed Critical Fei Technologies Inc
Publication of BR0014146A publication Critical patent/BR0014146A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"APARELHO E MéTODO PARA ANESTESIAR A REGIãO CERVICAL DE UMA FêMEA". é fornecido um aparelho novo e útil para liberar um anestésico localmente na região cervical de uma fêmea, em que o aparelho compreende um anel tendo uma superfície e no mínimo uma depressão sobre a superfície. Uma composição anestésica compreendendo um agente anestésico e um excipiente são colocados dentro de no mínimo uma depressão. O anel compreende um material inerte farmaceuticamente aceitável que é biocompatível. Além disso, o anel é de tamanho suficiente de tal modo que pode ser inserido no canal vaginal de uma fêmea. No canal vaginal, o agente anestésico é imediatamente liberado da composição anestésica e anestesia diretamente a região cervical.
BR0014146-1A 1999-08-26 2000-08-24 Aparelho e método para anestesiar a região cervical de uma fêmea BR0014146A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/383,887 US6264973B1 (en) 1999-08-26 1999-08-26 Apparatus and method for anesthetizing the cervical region of a female
PCT/US2000/023265 WO2001013780A2 (en) 1999-08-26 2000-08-24 Apparatus and method for anesthetizing the cervical region of a female

Publications (1)

Publication Number Publication Date
BR0014146A true BR0014146A (pt) 2002-11-26

Family

ID=23515147

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014146-1A BR0014146A (pt) 1999-08-26 2000-08-24 Aparelho e método para anestesiar a região cervical de uma fêmea

Country Status (9)

Country Link
US (1) US6264973B1 (pt)
EP (1) EP1210040A4 (pt)
JP (1) JP2003507109A (pt)
AU (1) AU767720B2 (pt)
BR (1) BR0014146A (pt)
CA (1) CA2383027C (pt)
IL (2) IL148340A0 (pt)
MX (1) MXPA02002069A (pt)
WO (1) WO2001013780A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
DE602004026173D1 (de) * 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US20070043332A1 (en) * 2003-07-10 2007-02-22 Galen (Chemiclas) Liimited Intravaginal drug delivery devices
US8603528B2 (en) * 2004-09-16 2013-12-10 Abyrx, Inc. Compositions and method for the reduction of post-operative pain
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
EP2170276B1 (en) * 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
US20090054915A1 (en) * 2007-08-23 2009-02-26 Peter Meier Obstruction of uterine arteries to treat uterine fibroids using mechanical instruments to twist the vessels
CN101779994B (zh) * 2010-01-15 2011-03-23 王磊光 立体宫内节育器
WO2012024461A2 (en) * 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
SE539540C2 (sv) 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2017165707A1 (en) * 2016-03-24 2017-09-28 Juniper Pharmaceuticals, Inc. Vaginal administration of agents for treating and preventing pain associated with gynecological medical procedures
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
ES2058503T5 (es) 1988-03-29 1999-04-16 Univ Florida Formulaciones farmaceuticas para uso parenteral.
US5295984A (en) * 1989-12-07 1994-03-22 Ultrafem, Inc. Vaginal discharge collection device and intravaginal drug delivery system
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5635159A (en) 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5597849A (en) 1994-11-14 1997-01-28 Medical Polymer Technologies, Inc. Stick formulations for topical drug delivery of therapeutic agents and uses thereof
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
DE19526031A1 (de) 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Rückenschmerz und Muskelverspannung
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea

Also Published As

Publication number Publication date
IL148340A (en) 2013-06-27
EP1210040A4 (en) 2003-02-12
AU767720B2 (en) 2003-11-20
CA2383027A1 (en) 2001-03-01
WO2001013780A3 (en) 2001-06-07
AU7069000A (en) 2001-03-19
WO2001013780A2 (en) 2001-03-01
MXPA02002069A (es) 2003-08-20
CA2383027C (en) 2010-01-26
US6264973B1 (en) 2001-07-24
JP2003507109A (ja) 2003-02-25
IL148340A0 (en) 2002-09-12
EP1210040A2 (en) 2002-06-05

Similar Documents

Publication Publication Date Title
BR0014146A (pt) Aparelho e método para anestesiar a região cervical de uma fêmea
LU91065I2 (fr) Drospirenone en combinaison avec oestradiol et leurs dérivés pharmaceutiquement acceptables (Allurene-Angeliq)
IL211288A (en) Medical vaginal preparations to reduce or relieve uterine rhythm, and use of anti-arrhythmic therapy in the preparation of vaginal drugs to reduce or relieve uterine rhythm
BR0109536A (pt) Derivação auto-expansìvel recuperável
AR024228A1 (es) Una composicion farmaceutica que comprende un sensibilizador de insulina y otro agente antidiabetico
AR003908A1 (es) Tableta de liberacion controlada
BR9914251A (pt) Formulações orais de liberação sustentada
CY1109636T1 (el) Συνθεση στοματικης δοσης παρατεταμενης απελευθερωσης
BR0014928A (pt) Dispositivo e processo para distribuição de medicamento para um olho humano
BG104620A (en) Oral pharmaceutical extended release dosage form
ZA9410263B (en) Accelerated release composition containing bromocriptine
HK1022437A1 (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP1139753A4 (en) PREPARATIONS FOR THE TREATMENT OF DISEASES AND METHODS RELATED THERETO
BR0007360A (pt) Composição de liberação controlada
HK1053254A1 (en) Device and method for treating urinary incontinence in females
EP0966966A3 (en) Nefazodone dosage form
CA2326198A1 (en) Cosolvent formulations
CO4910139A1 (es) Formulaciones en particulas revestidas
HK1040920A1 (en) Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent.
BR9809571A (pt) Composição medicinal e processo para produzì-la
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
ES2133152T3 (es) Composicion de tiotepa liofilizada estable.
PL316079A1 (en) Antiussive composition containing an antitussive agent and benzidamine

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: APRESENTE PROCURACAO AUTENTICADA EM NOME DE: FEI TECHNOLOGIES, INC.; PARA DAR ANDAMENTO AO PROCESSO.

B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: ANULACAO DA EXIGENCIA POR TER SIDO INDEVIDA.

B25A Requested transfer of rights approved

Owner name: BARR LABORATORIES, INC. (US)

Free format text: TRANSFERIDO DE: ENHANCE PHARMACEUTICALS, INC.

B25A Requested transfer of rights approved

Owner name: DURAMED PHARMACEUTICALS, INC. (US)

Free format text: TRANSFERIDO DE: BARR LABORATORIES, INC.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO COM BASE NO(S) ART.(S) 8O EM VISTA DO(S) ART.(S) 13 DA LEI DE PROPRIEDADE INDUSTRIAL NO 9.279 DE 14/05/1996.

B09T Decision of refusal: decision cancelled [chapter 9.2.1 patent gazette]

Free format text: REFERENTE A RPI NO 1995 DE 31/03/2009, ITEM DE DESPACHO 9.2

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO COM BASE NO(S) ART.(S) 8O EM VISTA DO ARTIGO 13 DA LPI 9.279/96

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: ANULADA A PUBLICACAO DA MANUTENCAO DO INDEFERIMENTO POR TER SIDO INDEVIDA.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25E Requested change of name of applicant rejected

Owner name: DURAMED PHARMACEUTICALS, INC. (US)

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 860160003940 DE 06/01/2016, CONFORME DISPOSTO NO ART. 59 DA LEI 9279 DE 14/05/1996, PELO FATO DO PEDIDO DE PATENTE TER SIDO INDEFERIDO NA RPI 2014 DE 11/08/2009 COM DECISAO MANTIDA EM GRAU DE RECURSO PUBLICADO NA RPI 2201 DE 12/03/2013.

Owner name: DURAMED PHARMACEUTICALS, INC. (US)